H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 1, 2005, Pages 77-82

  Itagaki, Shirou ^a   Saito, Yoshitaka ^a   Kubo, Sayaka ^a   Otsuka, Yukio ^a   Yamamoto, Yuta ^a   Kobayashi, Masaki ^a   Hirano, Takeshi ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEFRADINE; CEFTIBUTEN; CEFTIBUTEN PROTON COTRANSPORTER; COTRANSPORTER; GLYCYLSARCOSINE; NATEGLINIDE; PEPTIDE TRANSPORTER 1; PROTON; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRUSH BORDER; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; MALE; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE ABSORPTION;

ANIMALS; BIOLOGICAL TRANSPORT; CEPHALOSPORINS; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOGLYCEMIC AGENTS; INTESTINE, SMALL; MICROVILLI; PHENYLALANINE; PROTONS; RATS;

EID: 11844304351     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.074021     Document Type: Article

References (20)

1. Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, and Sinko PJ (1998) Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun 250:246-251.
2. Chu XY, Sanchez-Castano GP, Higaki K, Oh DM, Hsu CP, and Amidon GL (2001) Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. J Pharmacol Exp Ther 299:575-582.
3. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V, and Leibach FH (1995) Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J Biol Chem 270:25672-25677.
4. Ganapathy ME, Huang W, Wang H, Ganapathy V, and Leibach FH (1998) Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 246:470-475.
5. Han HK, Rhie JK, Oh DM, Saito G, Hsu CP, Stewart BH, and Amidon GL (1999) CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. J Pharm Sci 88:347-350.
6. Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N, and Maki T (1997) Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Br J Pharmacol 120:137-145.
7. Iseki K, Sugawara M, Sato K, Naasani I, Hayakawa T, Kobayashi M, and Miyazaki K (1999) Multiplicity of the H+-dependent transport mechanism of dipeptide and anionic beta-lactam antibiotic ceftibuten in rat intestinal brush-border membrane. J Pharmacol Exp Ther 289:66-71.
8. Itagaki S, Sugawara M, Kobayashi M, Nishimura S, Fujimoto M, Miyazaki K, and Iseki K (2003) Major role of organic anion transporters in the uptake of phenolsulfonphthalein in the kidney. Eur J Pharmacol 475:85-92.
9. Itoh T, Itagaki S, Sasaki K, Hirano T, Takemoto I, and Iseki K (2004) Pharmacokinetic modulation of irinotecan metabolites by sulphobromophthalein in rats. J Pharm Pharmacol 56:809-812.
10. Katsura T and Inui KI (2003) Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metab Pharmacokinet 18:1-15.
11. Kessler M, Acuto O, Storelli C, Murer H, Muller M, and Semenza G (1978) A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes: their use in investigating some properties of D-glucose and choline transport systems. Biochim Biophys Acta 506:136-154.
12. Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, and Leibach FH (1995) Human intestinal H+/peptide cotransporter: cloning, functional expression and chromosomal localization. J Biol Chem 270:6456-6463.
13. Lowry OH, Eosebrough NJ, Fair AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
14. Martinez MN and Amidon GL (2002) A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol 42:620-643.
15. Mizuno N and Sugiyama Y (2002) Drug transporters: their role and importance in the selection and development of new drugs. Drug Metab Pharmacokinet 17:93-108.
16. Okamura A, Emoto A, Koyabu N, Ohtani H, and Sawada Y (2002) Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1. Br J Pharmacol 137:391-399.
17. Sato Y, Nishikawa M, Shinkai H, and Sukegawa E (1991) Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) and its stimulatory effect on insulin secretion in animals. Diabetes Res Clin Pract 12:53-59.
18. Shinkai H, Toi K, Kumashiro I, Seto Y, Fukuma M, Dan K, and Toyoshima S (1988) N-acylphenylalanines and related compounds: a new class of oral hypoglycemic agents. J Med Chem 31:2092-2097.
19. Terada T, Sawada K, Saito H, Hashimoto Y, and Inui KI (2000) Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2. Eur J Pharmacol 392:11-17.
20. Wenzel U, Thwaites DT, and Daniel H (1995) Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter. Br J Pharmacol 116:3021-3027.